1. Home
  2. BIOX vs ALLO Comparison

BIOX vs ALLO Comparison

Compare BIOX & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIOX
  • ALLO
  • Stock Information
  • Founded
  • BIOX 2001
  • ALLO 2017
  • Country
  • BIOX Argentina
  • ALLO United States
  • Employees
  • BIOX N/A
  • ALLO N/A
  • Industry
  • BIOX Agricultural Chemicals
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BIOX Industrials
  • ALLO Health Care
  • Exchange
  • BIOX Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • BIOX 407.2M
  • ALLO 438.2M
  • IPO Year
  • BIOX N/A
  • ALLO 2018
  • Fundamental
  • Price
  • BIOX $7.22
  • ALLO $1.84
  • Analyst Decision
  • BIOX Strong Buy
  • ALLO Strong Buy
  • Analyst Count
  • BIOX 5
  • ALLO 10
  • Target Price
  • BIOX $13.90
  • ALLO $10.06
  • AVG Volume (30 Days)
  • BIOX 183.8K
  • ALLO 3.0M
  • Earning Date
  • BIOX 02-06-2025
  • ALLO 03-13-2025
  • Dividend Yield
  • BIOX N/A
  • ALLO N/A
  • EPS Growth
  • BIOX N/A
  • ALLO N/A
  • EPS
  • BIOX 0.02
  • ALLO N/A
  • Revenue
  • BIOX $441,266,821.00
  • ALLO $43,000.00
  • Revenue This Year
  • BIOX $3.05
  • ALLO N/A
  • Revenue Next Year
  • BIOX $10.53
  • ALLO N/A
  • P/E Ratio
  • BIOX $297.29
  • ALLO N/A
  • Revenue Growth
  • BIOX 7.95
  • ALLO 26.47
  • 52 Week Low
  • BIOX $5.71
  • ALLO $1.78
  • 52 Week High
  • BIOX $14.05
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • BIOX 61.52
  • ALLO 37.90
  • Support Level
  • BIOX $6.77
  • ALLO $2.11
  • Resistance Level
  • BIOX $7.12
  • ALLO $2.10
  • Average True Range (ATR)
  • BIOX 0.40
  • ALLO 0.17
  • MACD
  • BIOX 0.08
  • ALLO -0.02
  • Stochastic Oscillator
  • BIOX 91.73
  • ALLO 9.68

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: